Código QR (código de barras bidimensional)

Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer

Yanmei Wu,1 Yu Zhang,2 Hao Pi,1 Yuan Sheng1 1Department of Breast and Thyroid Surgery, Changhai Hospital, Navy Medical University, Shanghai 200433, People’s Republic of China; 2Medical Affairs, Pfizer Biopharmaceutical Group, Shanghai 200041, People’s Republic of ChinaCorrespondence: Yua...

ver descrição completa

Na minha lista:
Principais autores: Wu Y, Zhang Y, Pi H, Sheng Y
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2020-05-01
coleção:Cancer Management and Research
Assuntos:
cdk4/6 inhibitor
breast cancer
mechanism
clinical efficacy
resistance
Acesso em linha:https://www.dovepress.com/current-therapeutic-progress-of-cdk46-inhibitors-in-breast-cancer-peer-reviewed-article-CMAR
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados